Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

Published on : Dec-2018 | List of Tables : 46 | List of Figures : 211 | No. of Pages : 170 | Report Code : FACT358MR | Format :

Key Findings

FDA Streamlines Tedious Regulatory Process of Cancer Profiling Test Authorization

The U.S. Food and Drug Administration (FDA) regulates the safety, effectiveness, sales and distribution of cancer profiling tests. On November 15, 2017, FDA authorized Memorial Sloan Kettering Cancer Center’s (MSK) IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) tumor profiling test. The test is capable of high throughput screening and identification of a higher number of mutations using biomarkers of different cancer types.

Along with this new test authorization, FDA recognized wider acceptance of cancer profiling tests for better treatment of cancer and streamlined policy framework for the efficient review process and faster availability of NGS-based cancer profiling tests. The new framework allows review of the tests by accredited third-party to reduce the test developer’s burden and streamline ensuing regulatory assessment procedures. This step has paved a way for NGS-based cancer profiling tests manufacturers to elude tedious regulatory process of authorization and faster entry to the market.

Fact.MR’s study offers incisive insights on the cancer profiling market. A summary of the report is available upon request.

global cancer profiling market size us y o y growth 2018 2028

Cancer Profiling Complements Ongoing Precision Oncology R&D Activities

Traditionally treated on the basis of body location with a one-size-fits-all approach, cancer treatment is evolved significantly wherein precision medicine has aided in better cancer management. Identification of the target mutation with cancer profiling assists in determining highly specific drug that delivers long-lasting remission and expansion of lifetime.

Personalized medicine approach in cancer treatment involves genetic information of an individual and his or her cancer cell profile. In addition, lifestyle, diet, microbiome and other information of an individual is also covered while determining the personalized treatment approach. As cancer profiling helps in delivering genetic information of cancer cells, ongoing R&D activities in the field of precision oncology present lucrative avenues for cancer profiling manufacturers.

Rising Cancer Burden Necessitates Utilization of Cancer Profiling Tests

According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for nearly 9.6 million deaths in 2018 worldwide. While major strides are being made to prevent cancer development, the medical community still need to address the estimates of new cancer cases projected in coming years. WHO estimates the global burden of cancer to have risen to 18.1 million new cases in 2018.

As the incidences of rare cancer continue to rise, personalized medicine is providing promising results in cancer treatment. Cancer profiling is aiding the personalized treatments by providing the identification of specific gene mutation and use of targeted therapies.

cancer profiling tests price analysis us unit by region

Development of Datasets and Interpretation Tools Increases Cancer Profiling Precision

Major R&D investments in the cancer profiling market are being utilized in developing platforms for genomic data and clinical information to enhance the current capabilities of genomic profiling tests for different types of cancers. The current landscape of cancer profiling is facing challenges of clinical translations due to lack of sufficient consensus for treatment development and time-consuming interpretation.

With the growing emphasis on collaborative treatment to address cancer treatment issues effectively, development of common datasets is underway which can be used to interpret cancer profiling results and improve the treatment of cancer patients.

The Blood Profiling Atlas in Cancer (BloodPAC) Consortium launched a dataset for liquid biopsies and announced public release and accessibility of initial dataset in February 2018. Max Cancer Center in India recently published development of a web-based genome profiling interpretation tool – DrAV tool. The tool provides a platform for genomic data extraction and analysis of clinical information to aid precision oncology and cancer profiling processes.

Limitations in Identification of Predictive Biomarkers to Hider Cancer Profiling Test Developments

As genomic instability and acquisition of mutations are the hallmarks of cancer, tumor heterogeneity continues to pose challenges for the identification, testing and development of cancer biomarkers. These challenges reach to drug development landscape wherein their implementation in clinical drug trials is advancing at a staggering pace.

For these reasons, the landscape of cancer therapy seeks potential strategies for the development of robust biomarkers that complements the evolving cancer alterations, thereby enabling efficient tumor biopsies using cancer profiling. While ongoing cancer therapeutic scenario is lagging behind in biomarker development, considerable investments are in pipeline and their outcome is expected to aid in the progress of cancer profiling landscape in the future.

For a detailed analysis of all the key factors in the cancer profiling market, request a sample.

Cancer Profiling Market - Competitive Landscape

In the competitive landscape of the cancer profiling market report, competition scenario of the market is explained in terms of a dashboard view of all the key players and their relative presence in the global market. The section has also identified prominent players in cancer profiling market, emerging players, mid-size players and other key players in the cancer testing market.

The section of company profiles delivers vital information such as product offerings, products in clinical trials and company developments. Few of the profiles players in the cancer profiling market report include F. Hoffmann La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific Inc, Abbott, Nanostring Technologies Inc,  Siemens AG, HTG Molecular Diagnostics, Inc, Perkin Elmer Inc, Agilent Technologies Inc, Negenomics Laboratory Inc, Genomic Health, Biogenex and Pacific Biosciences of California, Inc.

cancer profiling competition dashboard

The cancer profiling marketplace is marked by significant investments in R&D aimed at getting clinical approvals. Multiple cancer profiling tests received FDA approvals in recent past. For instance, in November 2017, FDA approved the IMPACT developed at the Memorial Sloan Kettering Cancer Center. It is an in vitro NGS-based diagnostic test with the capacity to identify a higher number of tumor biomarkers and rapid identification of mutations in 468 unique genes.

In December 2017, FoundationOne CDx (F1CDx) genomic cancer profiling test that can identify cancer-associated alterations in 324 genes and two type of genomic signature in any solid tumor.

In August 2018, Caris Life Sciences® announced the company’s selection by the Hoosier Cancer Research Network to perform cancer profiling for a new Phase II bladder cancer clinical trial of HCRN GU16-257.

For full coverage of the competitive landscape, get in touch with our experts.

Cancer Profiling - Definition

Cancer profiling is a type of molecular profiling that provides specific information of molecular and genetic makeup of cancer tissues or cells. The information reveals abnormalities or altered levels of gene expression and assists in medical professionals to determine focused treatment of different cancer types.

Cancer Profiling Market - About the Report

Fact.MR has compiled a study on the cancer profiling and published a new report titled, “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028.” The cancer profiling market report delivers a thorough analysis of the market that derives actionable and valuable insights.

The cancer profiling market report delivers an in-depth assessment of the market landscape that covers important dynamics such as market drivers, restraints, opportunities and trends that hold significant influence on the growth of the cancer profiling market.

The cancer profiling market report focuses on providing authentic and viable insights of the market that help readers to understand and devise strategies to enter or ensure market sustenance.

Cancer Profiling Market Structure

The cancer profiling market is studied thoroughly for different facets such as types of cancer and associated diagnostic testing methods. In addition, regulation and reimbursement scenario is also considered to design the cancer profiling market structure. The cancer profiling market is segmented on the basis of product type, indication, end user and test type. The cancer profiling market is also studied for key regions to derive global forecast.

cancer profiling market taxonomy

Based on product type, the cancer profiling market is segmented into instruments and consumables wherein instruments cover IHC, FISH, PCR instruments, DNA sequencer and fragment analyzer. The consumables segment covers reagents & kits and others ancillaries (probes, holders, etc.)

Based on indication, the cancer profiling market is segmented into breast cancer, colorectal cancer, ovarian cancer, melanoma, kidney cancer, lung cancer (including NSCLC) and rare cancer.

Hospitals, diagnostic centers, cancer research institutes and others are covered in the end-user segment of the cancer profiling market. Based on test type, the cancer profiling market is segmented into immunohistochemistry (IHC), Fluorescence in situ Hybridization (FISH), Quantitative Polymerase Chain Reaction (qPCR), Next-Generation Sequencing (NGS), Sanger sequencing and fragment analysis.

In the regional analysis, cancer epidemiology of all the key regions is thoroughly studied. Key regions included in the cancer profiling market study are North America, Latin America, Europe, CIS & Russia, Japan, APEJ and MEA. 

Cancer Profiling Market - Additional Questions Answered

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

  • Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
  • Which region presents considerable utilization of cancer profiling tools?
  • Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
  • Which end-user will register leading utilization of cancer profiling tests during the forecast period?

Cancer Profiling Market - Research Methodology

A robust research methodology is used to derive the insights and forecast of the cancer profiling market. Study of the cancer profiling market is based on a systematic approach that follows the methodology of the research.

The research entails elaborated interviews with industry savants as well as study of cancer profiling industry data. The former comprised primary research approach whereas the latter included secondary research. In the research methodology section of the cancer profiling market report, sources used to carry out primary and secondary research are also given that enable readers to determine the credibility of the data derived in the cancer profiling market report.

Request Methodology of this Report.

Report Description

Fact.MR has compiled a study on cancer profiling market and published a new report titled, “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028.” The cancer profiling market report delivers intelligent and actionable insights that are derived based on thorough analysis of all the vital facets of the market. Cancer profiling market forecast derived in the report are based on exhaustive assessment such as SWOT analysis, associated industry assessment as well as mega and micro trends that hold significant influence on the growth of the cancer profiling market.

To deliver a comprehensive outlook of the cancer profiling market, the report is divided into sophisticated segments that help readers to easily navigate through the report and completely fathom the cancer profiling market overview. The report is divided into a total of 17 chapters and a brief overview of all the chapters is provided below.

Chapter 1 - Executive Summary – Global Cancer Profiling Market

The cancer profiling market report commences with the chapter of executive summary. The highlighted numbers in executive summary provides the readers with a quick yet informative look of the cancer profiling market. In addition to market summary, the chapter also covers information such as megatrends and opportunity assessment in the cancer profiling market.

Chapter 2 - Market Overview

In the market overview chapter, the cancer profiling market report provides information on cancer profiling definition and introduction of the cancer profiling market. The chapter also discusses scope of the cancer profiling market report.

Chapter 3 - Market Dynamics

In this chapter of the cancer profiling market report, study of market dynamics in terms of market drivers, restraints, opportunities and trends is provided. The assessment of the cancer profiling market is carried out for the historical period 2013-2017 and forecast period 2018-2028. The chapter also covers economic factors that influence the product demand, forecast factors and their impact analysis.

Chapter 4 - Key Inclusions

This chapter of the cancer profiling market report delivers important market information such as regional pricing analysis by test, cancer epidemiology by region and regulatory scenario in cancer profiling market.

Chapter 5 - Global Cancer Profiling Market Analysis and Forecast

This chapter of the cancer profiling market report delivers information regarding market value analysis for historical and forecast period and a thorough market structure analysis for all the segments mentioned in the cancer profiling market taxonomy.

Chapter 6 - North America Cancer Profiling Market Analysis

The chapter provides information on the cancer profiling market performance in the North America region. The chapter begins with North America cancer profiling market outlook in terms of market forecast value analysis. Country-wise analysis of the cancer profiling market includes study of demand assessment in the Unites States and Canada. In addition, North America cancer profiling market assessment includes thorough analysis of all the market segments.

Chapter 7 - Latin America Cancer Profiling Market Analysis

In this chapter of the cancer profiling market report, market performance in Latin America region is provided. The regional analysis begins with Latin America cancer profiling market outlook and in the ensuing section readers can find a thorough country-wise market analysis and an exhaustive study of all the market segments of the cancer profiling market.

Country-wise analysis of the Latin America cancer profiling market includes study of the market in Brazil, Mexico and Rest of LATAM.

Chapter 8 - Europe Cancer Profiling Market Analysis

In this chapter, readers can get information regarding cancer profiling market performance in Europe region. Country-wise analysis of the Europe cancer profiling market includes study of demand assessment in EU-4, the UK, Benelux, Nordic and rest of Europe. In addition, regional analysis also includes in-depth analysis of the cancer profiling market structure.

Chapter 9 - CIS & Russia Cancer Profiling Market Analysis

The regional analysis of cancer profiling market in CIS & Russia can be found in this chapter. The cancer profiling market study in CIS & Russia includes market attractive analysis, heat map analysis and impact assessment of different market forces.

Chapter 10 - Japan Cancer Profiling Market Analysis and Forecast

In this chapter of the cancer profiling market report, readers can find market performance in Japan. Market trends prevailing in the country are considered to derive the market performance. In addition, country’s market analysis also covers impact assessment of different market forces.

Chapter 11- APEJ Cancer Profiling Market Analysis and Forecast

Cancer profiling market performance in APEJ region is provided in this chapter. The regional forecast is based on country-wise analysis of India, ASEAN, South Korea, ANZ and rest of APEJ. Cancer profiling market study in APEJ also covers in-depth study of market structure.

Chapter 12- MEA Cancer Profiling Market Analysis and Forecast

Cancer profiling market performance in Middles Ease and Africa is provided in this chapter. Regional analysis covers country-wise demand assessment in GCC countries, South Africa, Turkey and rest of MEA. A thorough analysis of the cancer profiling market structure is also covered to derive MEA cancer profiling market forecast.

Chapter 13 - Global Cancer Profiling Market Value (US$ Mn) and Volume (‘000 tests) Analysis, By Tests Type, 2017

This chapter of the report provides information on different test types of the cancer profiling and their market size in terms of value and volume. The analysis is carried out for historical period 2013-2017 and forecast period 2018-2028. Demand assessment of different tests includes Immunohistochemistry (IHC), Fluorescence In situ Hybridization (FISH), Quantitative Polymerase Chain Reaction (qPCR), Next-Generation Sequencing (NGS), Sanger Sequencing and Fragment Analysis.

Chapter 14 - Competitive Assessment

In the chapter of competitive assessment, the cancer profiling market report provides a dashboard view of all the key players in the cancer profiling market and a competitive analysis of the cancer profiling market.

Chapter 15 - Company Profiles

In this chapter of the company profiles, the cancer profiling market report provides information such as product offerings, product approvals, notable developments and key strategies adopted by key market players.

Chapter 16 - Assumptions and Acronyms Used

In this chapter of the cancer profiling market report, readers can find a comprehensive list of assumptions and acronyms used in the cancer profiling market report.

Chapter 17 - Research Methodology

The chapter provides information on the research methodology followed during the course of the cancer profiling market study. The section also provides primary and secondary research approaches used during the cancer profiling market research and related resources used.

1. Executive Summary – Global Cancer Profiling Market
   1.1. Market Summary
   1.2. Analysis Summary
   1.3. Megatrends in Cancer Profiling Market
   1.4. Opportunity Assessment
   1.5. Wheel of Fortune Opportunity Analysis
   1.6. Fact.MR View Point

2. Market Overview
   2.1. Market Introduction
   2.2. Market Definition
   2.3. Scope of the Report

3. Market Dynamics
   3.1. Macro - Economic Factors Influencing Demand
   3.2. Key Growth Drivers and Impact Analysis
   3.3. Industry Challenges and Restraints
   3.4. Forecast Factors and Relevance of Impact

4. Key Inclusions
   4.1. Regional Pricing Analysis by Test (2017)
   4.2. Cancer Epidemiology By Region, 2017
   4.2. PORTER's Analysis
   4.2. Cancer Profiling Regulatory Senario

5. Global Cancer Profiling Market Analysis and Forecast
   5.1. Global Cancer Profiling Market Outlook
        5.1.1. Market Value Analysis & Forecast
   5.2. Global Cancer Profiling Market Analysis by Product Type
        5.2.1. Instruments
               5.2.1.1. Immunohistochemistry (IHC) Analyzers
               5.2.1.2. Fluorescence In situ Hybridization (FISH) Instruments
               5.2.1.3. PCR instruments
               5.2.1.4. DNA Sequencer
               5.2.1.5. Fragment Analyzer
        5.2.2. Consumables
               5.2.2.1. Reagents & Kits
               5.2.2.2. Other Ancillary (probes, holders etc.)
        5.2.3. Market Attractiveness Analysis by Product Type
   5.3. Global Cancer Profiling Market Analysis by Indication
        5.3.1. Breast Cancer
        5.3.2. Colorectal Cancer
        5.3.3. Ovarian Cancer
        5.3.4. Melanoma
        5.3.5. Kidney Cancer
        5.3.6. Lung Cancer (including NSCLC)
        5.3.7. Rare Cancers
        5.3.8. Market Attractiveness Analysis by Indication
   5.4. Global Cancer Profiling Market Analysis by End User
        5.4.1. Hospitals
        5.4.2. Diagnostic Centres
        5.4.3. Cancer Research Institutes
        5.4.4. Others
        5.4.5. Market Attractiveness Analysis by End User

6. North America Cancer Profiling Market Analysis
   6.1. Introduction
        6.1.1. North America Cancer Profiling Market Outlook
   6.2. North America Cancer Profiling Market Outlook
        6.2.1. Market Value (US$ Mn) Forecast and Analysis
        6.2.2. Country Wise Demand Assessment
               6.2.2.1. US Market Value Share
               6.2.2.2. Canada Market Value Share
   6.3. North America Cancer Profiling Market Analysis by Product Type
        6.3.1. Value (US$ Mn) Forecast by Product Type
        6.3.2. Y-o-Y Growth Comparison by Product Type
   6.4. North America Cancer Profiling Market Analysis by Indication
        6.4.1. Value (US$ Mn) Forecast by Indication
        6.4.2. Y-o-Y Growth Comparison by Indication
   6.5. North America Cancer Profiling Market Analysis by End User
        6.5.1. Value (US$ Mn) Forecast by End User
        6.5.2. Y-o-Y Growth Comparison by End User
   6.6. Market Attractiveness Analysis
   6.7. Heat Map Analysis
   6.8. Impact Assessment of Market Forces

7. Latin America Cancer Profiling Market Analysis
   7.1. Introduction
        7.1.1. Latin America Cancer Profiling Market Outlook
   7.2. Latin America Cancer Profiling Market Outlook
        7.2.1. Market Value (US$ Mn) Forecast and Analysis
        7.2.2. Country Wise Demand Assessment
               7.2.2.1. Brazil Market Value Share
               7.2.2.2. Mexico Market Value Share
               7.2.2.3. Rest of LATAM Market Value Share
   7.3. Latin America Cancer Profiling Market Analysis by Product Type
        7.3.1. Value (US$ Mn) Forecast by Product Type
        7.3.2. Y-o-Y Growth Comparison by Product Type
   7.4. Latin America Cancer Profiling Market Analysis by Indication
        7.4.1. Value (US$ Mn) Forecast by Indication
        7.4.2. Y-o-Y Growth Comparison by Indication
   7.5. Latin America Cancer Profiling Market Analysis by End User
        7.5.1. Value (US$ Mn) Forecast by End User
        7.5.2. Y-o-Y Growth Comparison by End User
   7.6. Market Attractiveness Analysis
   7.7. Heat Map Analysis
   7.8. Impact Assessment of Market Forces

8. Europe Cancer Profiling Market Analysis
   8.1. Introduction
        8.1.1. Europe Cancer Profiling Market Outlook
   8.2. Europe Cancer Profiling Market Outlook
        8.2.1. Market Value (US$ Mn) Forecast and Analysis
        8.2.2. Country Wise Demand Assessment
               8.2.2.1. EU -4 Market Value Share
               8.2.2.2. UK Market Value Share
               8.2.2.3. Benelux Market Value Share
               8.2.2.4. Nordic Market Value Share
               8.2.2.5. Rest of Europe Market Value Share
   8.3. Europe Cancer Profiling Market Analysis by Product Type
        8.3.1. Value (US$ Mn) Forecast by Product Type
        8.3.2. Y-o-Y Growth Comparison by Product Type
   8.4. Europe Cancer Profiling Market Analysis by Indication
        8.4.1. Value (US$ Mn) Forecast by Indication
        8.4.2. Y-o-Y Growth Comparison by Indication
   8.5. Europe Cancer Profiling Market Analysis by End User
        8.5.1. Value (US$ Mn) Forecast by End User
        8.5.2. Y-o-Y Growth Comparison by End User
   8.6. Market Attractiveness Analysis
   8.7. Heat Map Analysis
   8.8. Impact Assessment of Market Forces

9. CIS & Russia Cancer Profiling Market Analysis
   9.1. Introduction
        9.1.1. CIS & Russia Cancer Profiling Market Outlook
   9.2. CIS & Russia Cancer Profiling Market Outlook
        9.2.1. Market Value (US$ Mn) Forecast and Analysis
   9.3. CIS & Russia Cancer Profiling Market Analysis by Product Type
        9.3.1. Value (US$ Mn) Forecast by Product Type
        9.3.2. Y-o-Y Growth Comparison by Product Type
   9.4. CIS & Russia Cancer Profiling Market Analysis by Indication
        9.4.1. Value (US$ Mn) Forecast by Indication
        9.4.2. Y-o-Y Growth Comparison by Indication
   9.5. CIS & Russia Cancer Profiling Market Analysis by End User
        9.5.1. Value (US$ Mn) Forecast by End User
        9.5.2. Y-o-Y Growth Comparison by End User
   9.6. Market Attractiveness Analysis
   9.7. Heat Map Analysis
   9.8. Impact Assessment of Market Forces

10. Japan Cancer Profiling Market Analysis and Forecast
   10.1.Introduction
        10.1.1. Japan Cancer Profiling Market Outlook
   10.2.Japan Cancer Profiling Market Outlook
        10.2.1. Market Value (US$ Mn) Forecast and Analysis
   10.3.Japan Cancer Profiling Market Analysis by Product Type
        10.3.1. Value (US$ Mn) Forecast by Product Type
        10.3.2. Y-o-Y Growth Comparison by Product Type
   10.4.Japan Cancer Profiling Market Analysis by Indication
        10.4.1. Value (US$ Mn) Forecast by Indication
        10.4.2. Y-o-Y Growth Comparison by Indication
   10.5.Japan Cancer Profiling Market Analysis by End User
        10.5.1. Value (US$ Mn) Forecast by End User
        10.5.2. Y-o-Y Growth Comparison by End User
   10.6.Market Attractiveness Analysis
   10.7.Heat Map Analysis
   10.8.Impact Assessment of Market Forces

11. APEJ Cancer Profiling Market Analysis and Forecast
   11.1.Introduction
        11.1.1. APEJ Cancer Profiling Market Outlook
   11.2.APEJ Cancer Profiling Market Outlook
        11.2.1. Market Value (US$ Mn) Forecast and Analysis
        11.2.2. Country Wise Demand Assessment
               11.2.2.1. Greater China Market Value Share
               11.2.2.2. India Market Value Share
               11.2.2.3. ASEAN Market Value Share
               11.2.2.4. South Korea Market Value Share
               11.2.2.5. ANZ Market Value Share
               11.2.2.6. Rest of APEJ Market Value Share
   11.3.APEJ Cancer Profiling Market Analysis by Product Type
        11.3.1. Value (US$ Mn) Forecast by Product Type
        11.3.2. Y-o-Y Growth Comparison by Product Type
   11.4.APEJ Cancer Profiling Market Analysis by Indication
        11.4.1. Value (US$ Mn) Forecast by Indication
        11.4.2. Y-o-Y Growth Comparison by Indication
   11.5.APEJ Cancer Profiling Market Analysis by End User
        11.5.1. Value (US$ Mn) Forecast by End User
        11.5.2. Y-o-Y Growth Comparison by End User
   11.6.Market Attractiveness Analysis
   11.7.Heat Map Analysis
   11.8.Impact Assessment of Market Forces

12. MEA Cancer Profiling Market Analysis and Forecast
   12.1.Introduction
        12.1.1. MEA Cancer Profiling Market Outlook
   12.2.MEA Cancer Profiling Market Outlook
        12.2.1. Market Value (US$ Mn) Forecast and Analysis
        12.2.2. Country Wise Demand Assessment
               12.2.2.1. GCC Countries Market Value Share
               12.2.2.2. South Africa Market Value Share
               12.2.2.3. Turkey Market Value Share
               12.2.2.4. Rest of MEA Market Value Share
   12.3.MEA Cancer Profiling Market Analysis by Product Type
        12.3.1. Value (US$ Mn) Forecast by Product Type
        12.3.2. Y-o-Y Growth Comparison by Product Type
   12.4.MEA Cancer Profiling Market Analysis by Indication
        12.4.1. Value (US$ Mn) Forecast by Indication
        12.4.2. Y-o-Y Growth Comparison by Indication
   12.5.MEA Cancer Profiling Market Analysis by End User
        12.5.1. Value (US$ Mn) Forecast by End User
        12.5.2. Y-o-Y Growth Comparison by End User
   12.6.Market Attractiveness Analysis
   12.7.Heat Map Analysis
   12.8.Impact Assessment of Market Forces

13. Global Cancer Profiling Market Value (US$ Mn) and Volume (‘000 tests) Analysis, By Tests Type, 2017
   13.1.Introduction
   13.2.North America Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
        13.2.1. Immunohistochemistry (IHC)
        13.2.2. Fluorescence In situ Hybridization (FISH)
        13.2.3. Quantitative Polymerase Chain Reaction (qPCR)
        13.2.4. Next-Generation Sequencing (NGS)
        13.2.5. Sanger Sequencing
        13.2.6. Fragment Analysis
   13.3.Latin America Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.4.Europe Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.5.CIS & Russia Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.6.APEJ Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.7.Japan Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.8.MEA Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017

14. Competitive Assessment
   14.1.Global Cancer Profiling Market Competition - a Dashboard View
   14.2.Global Cancer Profiling Market Structure (2017)

15. Company Profiles
   15.1.Qiagen N.V.
        15.1.1. Geographical Footprint
        15.1.2. Regional Revenue
        15.1.3. Key Financials
        15.1.4. SWOT Analysis
   15.2.Roche Molecular Systems INC.
   15.3.Abbott Laboratories
   15.4.Siemens AG
   15.5.Neogenomics Laboratories
   15.6.Illumina, Inc.
   15.7.HTG Molecular Diagnostic
   15.8.PerkinElmer Inc.
   15.9.Genomic Health INC.
   15.10.Nanostring Technologies, Inc.
   15.11.BioGenex
   15.12.Thermo Fisher Scientific Inc.
   15.13.Pacific Biosciences
   15.14.Agilent Technologies, Inc.

16. Assumptions and Acronyms Used

17. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028